In vitro diagnostics company EKF Diagnostics has announced the worldwide launch of the new STAT-Site M ß-HB, following successful CE marking. The new quantitative strip-based test for ß-Hydroxybutyrate (ß-HB) provides an assessment of diabetic ketoacidosis (DKA), delivering results in less than 80 seconds. EKF will premier STAT-Site M ß-HB at the American Association for Clinical Chemistry’s Annual Meeting and Clinical Lab Expo (AACC 2013) next week.
The presence and degree of ketosis can be rapidly assessed at the point-of-care by accurately measuring blood levels of ß-HB, which accounts for 78% of the three ketone bodies, from just 10 µL of serum or plasma. This provides useful information to provide quality care when monitoring DKA in newly diagnosed patients, while also reducing time and costs in an intensive care unit setting.
Also at AACC, to highlight the clinical utility of ß-HB for the screening and diagnosis of ketosis, EKF will host the AACC Industry Workshop “Metabolic Disturbances That Lead to ß-Hydroxybutyrate and Ketone Bodies.” The program will be presented by point-of-care specialist James Nichols, PhD, DABCC, FACB, Professor of Pathology, Microbiology & Immunology and Medical Director of Clinical Chemistry at Vanderbilt University School of Medicine. Attendees will learn about the critical interrelationships of glucose, diabetes mellitus, and conditions that lead to DKA. Learn more about the STAT-Site M ß-HB. The link includes a video of an informative lecture by Dr. Nichols.
